Driehaus Capital Management LLC Aclaris Therapeutics, Inc. Transaction History

Driehaus Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$5.63 - $7.84 $1.41 Million - $1.96 Million	-250,484 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$6.3 - $15.4 $1.59 Million - $3.89 Million	-252,512 Reduced 50.2%	250,484 $1.85 Million
Q3 2018 Nov 14, 2018	SELL	$14.38 - $20.89 $1.18 Million - $1.72 Million	-82,212 Reduced 14.05%	502,996 $7.3 Million
Q2 2018 Aug 14, 2018	SELL	$16.46 - $20.33 $98,233 - $121,329	-5,968 Reduced 1.01%	585,208 $11.7 Million
Q1 2018 May 15, 2018	BUY	$17.08 - $25.64 $1.16 Million - $1.74 Million	67,748 Added 12.94%	591,176 $10.4 Million
Q4 2017 Feb 14, 2018	BUY	$21.47 - $27.8 $4.77 Million - $6.18 Million	222,254 Added 73.8%	523,428 $12.9 Million
Q3 2017 Nov 14, 2017	BUY	$23.02 - $28.8 $6.93 Million - $8.67 Million	301,174	301,174 $7.77 Million

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.